Lucy Scientific Discovery Inc. LSDI a company that makes early-stage psychedelics filed an amendment to its current dealer license with Health Canada add cocaine and heroinamong other in the list of permitted substances that he is authorized to manufacture.

The shift towards a public health response to the drug crisis will provide people who use substances with greater opportunities to connect to a growing range of harm reduction and treatment options. Currently Lucy is focused on developing psychedelic drugs for research purposes and hopes to offer safe access programs in the future. The Company holds licenses to manufacture several controlled substances, including psilocybin; MDMA; LSD; psilocin; N,N-DMT; Mescaline; and 2C-B.

“We look forward to a time when Lucy can safely deliver harm reduction programs around the world aimed at reducing the fatal and/or adverse consequences associated with the supply of adulterated medicines, particularly given that an overdose of Fentanyl is the leading cause of death among 18-45 year olds in the United States Chris McElvany, the company’s CEO. “It’s time to recognize that the failed war on drugs has inflicted additional harm on the masses worldwide, and harm reduction programs will lead to fewer deaths and more treatment options in the long term.”

The Benzinga Cannabis Capital Conference is back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is where DEALS are CLOSED, money raised, M&A started and companies meet investors and important partners. Join us April 11-12 at the Fontainebleau Miami Beach Hotel in Florida. Don’t miss it. Get your tickets now. Prices will rise very soon.

Photo of Louis Scheid At Unsplash